B and T Lymphocyte Associated (BTLA) (C-Term) Peptid
Kurzübersicht für B and T Lymphocyte Associated (BTLA) (C-Term) Peptid (ABIN8095342)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- C-Term
-
Verwendungszweck
- BTLA Peptide - C-terminal region
-
Sequenz
- SRPWLLYSLL PLGGLPLLIT TCFCLFCCLR RHQGKQNELS DTAGREINLV
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-BTLA Antibody (ARP62109_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Hintergrund
-
Background Information: This gene encodes a member of the immunoglobulin superfamily. The encoded protein contains a single immunoglobulin (Ig) domain and is a receptor that relays inhibitory signals to suppress the immune response. Alternative splicing results in multiple transcript variants. Polymorphisms in this gene have been associated with an increased risk of rheumatoid arthritis.
Alternative Symbols: BTLA1, CD272, FLJ16065, MGC129743
-
Molekulargewicht
- 32kDa
-
Gen-ID
- 151888
-
NCBI Accession
- NP_861445
-
UniProt
- Q7Z6A9
Target
-